Drawing for ACCUM

USPTO serial 90453057

ACCUM

Reviewed by CopyMark Law Group

Reg. 7178708Status 700Registered
Filing date
Status date
Registration date
Oct 3, 2023
Examiner
KEAM, ALEX S
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with ACCUM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Bradley L. Cohn

Bradley L. Cohn PATTISHALL, MCAULIFFE, NEWBURY, HILLIARD200 S. WACKER DRIVE, STE. 2900CHICAGO, IL 60606UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
042Research and development of vaccines and medicinesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 3, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Oct 3, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 18, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 18, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 28, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 12, 2023PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jun 5, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 5, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 5, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 1, 2023ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Jan 30, 2023GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jan 30, 2023GNSLLETTER OF SUSPENSION E-MAILED—
Jan 30, 2023CNSLSUSPENSION LETTER WRITTEN—
Jan 30, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 30, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 28, 2023ALIEASSIGNED TO LIE—
Jan 20, 2023ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Aug 18, 2022GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Aug 18, 2022GNSIINQUIRY TO SUSPENSION E-MAILED—
Aug 18, 2022CNSISUSPENSION INQUIRY WRITTEN—
Feb 17, 2022GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Feb 17, 2022GNSLLETTER OF SUSPENSION E-MAILED—
Feb 17, 2022CNSLSUSPENSION LETTER WRITTEN—
Feb 17, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 17, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 16, 2022ALIEASSIGNED TO LIE—
Feb 11, 2022ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Jan 18, 2022GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Jan 18, 2022GNSIINQUIRY TO SUSPENSION E-MAILED—
Jan 18, 2022CNSISUSPENSION INQUIRY WRITTEN—
Jul 16, 2021GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jul 16, 2021GNSLLETTER OF SUSPENSION E-MAILED—
Jul 16, 2021CNSLSUSPENSION LETTER WRITTEN—
Jul 15, 2021DOCKASSIGNED TO EXAMINER—
Apr 7, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 11, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance